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ABSTRACT
Background Patellofemoral pain is a common and 
often debilitating musculoskeletal condition. Clinical 
translation and evidence synthesis of patellofemoral 
pain research is compromised by heterogenous and 
often inadequately reported study details. This consensus 
statement and associated checklist provides standards 
for REPORTing of quantitative PatelloFemoral Pain 
(REPORT- PFP) research to enhance clinical translation 
and evidence synthesis, and support clinician 
engagement with research and data collection.
Method A three- stage Delphi process was initiated 
at the 2015 International Patellofemoral Research 
Network (iPFRN) retreat. An initial e- Delphi activity 
(n=24) generated topics and items, which were refined 
at the 2017 iPFRN retreat, and voted on prior to and 
following the 2019 iPFRN retreat (n=51 current and past 
retreat participants). Voting criteria included ’strongly 
recommended’ (essential), ’recommended’ (encouraged) 
and uncertain/unsure. An item was included in the 
checklist if ≥70% respondents voted ’recommended’. 
Items receiving ≥70% votes for ’strongly recommended’ 
were labelled as such.
Results The REPORT- PFP checklist includes 31 items 
(11 strongly recommended, 20 recommended), covering 
(i) demographics (n=2,4); (ii) baseline symptoms and 
previous treatments (n=3,7); (iii) outcome measures 
(2,4); (iv) outcomes measure description (n=1,2); (v) 
clinical trial methodology (0,3) and (vi) reporting study 
results (n=3,0).
Conclusion The REPORT- PFP checklist is ready to be 
used by researchers and clinicians. Strong stakeholder 
engagement from clinical academics during development 
means consistent application by the international 
patellofemoral pain research community is likely. 
Checklist adherence will improve research accessibility 
for clinicians and enhance future evidence synthesis.
INTRODUCTION
Patellofemoral pain is a common musculoskeletal 
condition. It affects 23% of the general population1 
and accounts for approximately 17% of all knee 
pain presentations to general practice.2 3 People 
with patellofemoral pain presenting to sport 
and exercise medicine clinicians are of varying 
ages and activity levels, and report anterior knee 
pain that is aggravated by activities loading the 
patellofemoral joint (ie, stairs, running, squatting, 
etc).4
Systematic reviews, clinical practice guidelines5 
and international consensus statements6 7 have 
been formulated to guide clinical practice for 
clinicians in how to treat people with patellofem-
oral pain. Yet, the credibility of recommendations 
and ‘how to’ guidance provided in these docu-
ments is compromised by heterogenous and often 
inadequately reported study details in the original 
research informing them. Our involvement in 14 
key systematic review and meta- analyses published 
in the past 5 years to 20205 8–20 has highlighted 
that key patient characteristics (eg, symptom dura-
tion, physical activity, body mass index (BMI), 
quality of life) and details of outcome measures 
(eg, validity, how to administer) are infrequently 
reported. This impedes trustworthy meta- analyses 
and prevents clinicians from judging the relevance 
of research findings to their patient population. 
The description of treatments provided in clin-
ical trials often lacks sufficient detail to allow 
for replication in confirmatory research or use in 
clinical practice.17 18 For example, a 2017 review 
of exercise- therapy reported that no clinical trial 
provided complete exercise programme details 
to allow replication.17 18 Frequently missing 
data such as group mean and variance for key 
outcomes in prospective,8 cross- sectional9–14 and 
intervention studies5 10 12 15–20 also compromises 
important meta- analysis needed to better under-
stand patellofemoral pain and guide practice.
The Enhancing the QUAlity and Transparency 
Of Health Research (EQUATOR) network21 
curates a library of quality checklists to guide 
reporting of studies, that typically focuses on 
particular methodologies (Strengthening the 
Reporting of Observational Studies in Epide-
miology (STROBE), Consolidated Standards of 
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research credibility but do not consider or enhance clinical 
translation.22 Condition- specific reporting checklists23–25 can 
complement these generic methodological tools by focussing 
on the specific factors required for reporting to be optimally 
clinically relevant. The aim of this study was to provide a 
clearly defined, and widely accepted set of agreed- upon stan-
dards for REPORTing of quantitative PatelloFemoral Pain 
(REPORT- PFP) study. Our goal is to enhance research transla-
tion to clinical practice, facilitate more trustworthy evidence 
synthesis, and guide clinicians on how to contribute to research 
and data collection in their practice.
METHODS
Design
A three- stage modified Delphi process was initiated at the 
2015 International Patellofemoral Research Network (iPFRN) 
retreat. Further work and discussions continued at the 2017 
iPFRN retreat, and the consensus was completed following the 
2019 iPFRN retreat (figure 1). The initial research design was 
undertaken by DM, CJB and SM using the principles outlined 
by Moher et al.26
Stage 1
A modified e- Delphi technique27 was facilitated via online ques-
tionnaires using password protected Google Forms (Mountain 
View, California, USA). The initial content was informed from 
previous similar reports,23 28–30 and initial scoping discussions 
among a core group of authors (DM, CJB, SM, MC, MvM, 
KC, MR, BV). All 50 attendees from the 2015 Manchester 
iPFRN retreat were invited via email to participate as inter-
national experts following the conclusion of the retreat. The 
initial scoping survey was followed by a priority agreement 
survey, then a priority ranking survey (online supplemental 
file 1). Twenty- four attendees responded to the first survey 
(response rate=48%), 22 responded to the second and 19 to 
the third. Responding healthcare professions included phys-
iotherapist/physical therapist (n=19), athletic trainer (n=1), 
sports medicine physician (n=2), human movement scientist 
(n=1) and other (n=1). Non- respondent participants in stage 
1 were not excluded from participating in future rounds.
SM, CJB and DM analysed the findings after each survey 
round. Feedback from multiple participants during this initial 
stage 1 e- Delphi identified that further discussion about prior-
ities and scope of this consensus were required to produce a 
more impactful document. Additionally, the recommended 
minimum number of 30 participants was not achieved for this 
e- Delphi process.31–34 Subsequently, analysis of information 
provided during stage 1 informed three distinct domains for 
further discussion and refinement at the 2017 iPFRN retreat, 
including (i) demographics; (ii) patient reported outcome 
measures and (iii) study and trial methodology.
Stage 2
At the 2017 Gold Coast iPFRN retreat (51 attendees, July 
2017), small groups (approximately 10–15 participants) 
discussed the three distinct domains identified in stage 1. 
These groups met for 30 min to discuss and refine the draft set 
of recommendations developed during stage 1. Each meeting 
was led by a content expert, who subsequently presented the 
proposed recommendations to the whole group. A further 
period of discussion, facilitated by CJB, was then used to 
refine each list. Recordings of discussions undertaken during 
the retreat were reviewed by CJB and group discussion leaders 
(BV, MR, NC, MvM, KC) to ensure all suggested final changes 
to draft recommendations were adopted.
Stage 3
A further Delphi process was initiated prior to the most recent 
iPFRN retreat in Milwaukee (54 attendees, September 2019), 
starting with a survey to facilitate voting on final recommen-
dations defined during stage 2 for demographics, patient 
reported outcome measures, and study trial and methodology. 
Review from a core group from the author panel (DM, CJB, 
MvM, KC, MR, BV, NC) grouped items to be voted into 
six sections, including (i) demographics; (ii) baseline symp-
toms and previous treatments; (iii) outcome measures; (iv) 
outcome measure description; (v) clinical trial methodology 
and (vi) reporting study results (online supplemental file 2). 
Following piloting, the survey was disseminated to all previous 
and 2019 iPFRN retreat participants (n=105). Final items to 
be voted on were succinct and clear statements. The survey 
also provided opportunity for feedback related to wording of 
each item as well as the option to suggest additional items 
for consideration. The core group could not define clear time-
frames for short- term, medium- term and long- term follow- up. 
Therefore, an open- ended question was added to the survey to 
collate ideas from survey respondents.
Figure 1 Timeline of the three stages and associated activities to 
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The voting survey was disseminated via ‘Survey Monkey’ 
(San Mateo, USA). We sought to recruit at least 30 participants, 
recommended as the minimum required for stable results (ie, 
unlikely to change with inclusion of additional participants) 
based on similar Delphi studies.31–34
The following voting criteria and wording was established for 
voting on each item:
 ► Strongly recommend: these items should be included and 
reported in all quantitative studies related to patellofemoral 
pain in order to meet consensus recommendations—that is, 
they are essential items.
 ► Recommend: encouraged to be considered and reported 
wherever relevant to the specific research question, but may 
not be considered applicable (ie, N/A) for some research 
studies—reporting N/A is therefore also possible for these 
items.
 ► Uncertain/unsure (please explain why).
We made an a priori decision to use a ≥70% agreement 
criterion to reach consensus on an item to be strongly recom-
mended or recommended, based on prior consensus derived 
recommendations.33
The pre- retreat survey finding discussion was led by CJB 
during the 2019 iPFRN retreat, followed by group discussions 
and feedback. The group also discussed the additional items 
proposed in pre- retreat survey responses, followed by a post- 
retreat consensus voting survey for these items. Additionally, 
the group discussion led to some items that had not reached 
the ≥70% agreement criterion initially, being included for 
post- retreat consensus voting. Following group discussion, it 
was decided this survey would only include two voting options 
for each item—‘recommend’ and ‘uncertain/unsure’, due to the 
later inclusion or re- voting for these items. This final post- retreat 
survey (online supplemental file 3) provided further opportunity 
for feedback on items included as strongly recommended and 
recommended from the pre- retreat survey voting. Completion 
of the post- retreat survey occurred during December 2019 and 
January 2020. A checklist of strongly recommended and recom-
mended reporting items, and specific suggestions for how to 
apply the checklist and what to report informed by author group 
discussion, was developed following the retreat.26
RESULTS
The consensus voting survey prior to the 2019 iPFRN retreat 
was completed by 51 current and past retreat participants (49% 
response rate) working in 10 countries (Australia=7; Brazil=7; 
Canada=3; Denmark=3; India=1; Italy=2; Kuwait=1; The 
Netherlands=2; UK=9; USA=16). The average completion 
time for the 58 questions was 25 min. There was substantial 
diversity in clinical experience treating patellofemoral pain 
patients (≤4 years=12 (24%); 5–10 years=9 (18%); 11–15 
years=15 (29%); ≥=15 (29%)), time treating patients per week 
(0–5 hours=32 (63%); 5–10 hours=10 (20%); 10–20 hours=3 
(6%); >20 hours=6 (12%)) and time conducting research 
(0–5 hours=8 (16%); 5–10 hours=6 (12%); 10–20 hours=9 
(18%); >20 hours 28 (56%)). Healthcare professional training 
of respondents included physiotherapy/physical therapy (n=26), 
athletic trainer (n=7) and medical (n=2).
The consensus voting outcomes prior to the 2019 iPFRN 
retreat are illustrated in figure 2 (22 items related to demo-
graphics, baseline symptoms and previous treatments), figure 3 
(nine items related to outcome measures) and figure 4 (10 items 
related to trial methodology and study results). During this 
voting round, no consistent recommendations were provided in 
open ended responses to what should define short- term (ranged 
2 weeks to 6 months), medium- term (ranged 2 weeks to 5 years) 
and long- term (ranged 4 weeks to >5 years).
The consensus voting survey after the 2019 iPFRN retreat was 
completed by 48 participants (46% response rate) working in 
nine countries (Australia=6; Brazil=6 Canada=2; Denmark=4; 
Italy=1; The Netherlands=3; Switzerland=1; UK=7; 
USA=18). Additional voting outcomes after the 2019 iPFRN 
retreat are illustrated in figure 5 (six items related to demo-
graphics and outcome measures). The final question ‘Do you 
have any final comments or suggestions?’ led to 11 responses. 
All indicated acceptance of the checklist, and no concerns or 
suggested changes to the items to be included as strongly recom-
mended or recommended were raised.
Strongly recommended items
Eleven items voted on were strongly recommended for reporting 
(≥70% voted strongly recommended), including demographic 
items age and sex (figure 2A); baseline symptom items pain 
severity, symptom duration and unilateral/bilateral symptoms 
(figure 2B); outcome measure items condition- specific patient- 
reported outcomes and pain severity (figure 3A); outcome 
measure description item describe assessment in adequate detail 
to allow replication (figure 3B); and reporting study results items 
reporting mean (SD), median (IQR) and 95% CIs for between 
group differences (figure 4B). Suggestions on what to report for 
each strongly recommended (ie, essential) item provided by the 
author panel are provided in online supplemental file 4, and are 
freely available in online ( www. ipfrn. org).
Figure 2 Consensus voting results for reporting demographics (A) and 
baseline symptoms and previous treatments (B). Vertical bar indicates 
70% threshold for strongly recommended (dark green crosses line) or 
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Recommended items
Twenty- eight items voted on were recommended (≥70% voted 
recommended or strongly recommended), including body mass, 
height, BMI, physical activity and source/setting/ location of 
participants (figure 2A); history of knee surgery, pain location, 
pain quality, crepitus, aggravating factors, other complaints/
musculoskeletal complaints/comorbidities (figure 2B) and 
ethnicity (figure 5); pain catastrophising, pain- related fear, health- 
related quality of life, physical activity (figure 3A), and global 
rating of change (GROC) and self- efficacy (figure 5); providing 
measurement properties of assessments and providing videos 
and/or images of assessments (figure 3B); following reporting 
guidelines from Complete Exercise Reporting Template (CERT), 
Template of Intervention Description and Replication (TIDiER), 
Toigo and Boutellier and EQUATOR, providing videos and/or 
images of treatments (figure 4A); and including 6, 13, 26 and 
52 weeks as preferred follow- up timeframes (figure 4B). Sugges-
tions on what to report for each recommended (ie, encouraged 
but not essential) item from the author panel are provided in 
online supplemental file 4, and are freely available in online ( 
www. ipfrn. org).
Not recommended/unsure
Four items did not reach consensus thresholds for recom-
mended, including baseline symptom item night pain (figure 2B); 
and demographic items socioeconomic status, work status and 
geographical location (figure 5).
Final checklist
All 11 strongly recommended (essential) items were included in 
the final checklist. The number of recommended (encouraged) 
items was reduced from 28 to 20 in the final checklist, facilitated 
via mergers and omissions. Specifically, (i) the three anthropo-
metric measures (height, body mass, BMI) were combined; (ii) 
the three psychological outcome measures (self- efficacy, pain- 
related fear, pain catastrophising) were combined; (iii) the three 
existing checklists for interventions (TIDiER, CERT, Toigo 
and Boutellier) were combined and (iv) two study results items 
were removed (aim for longer follow- up; use 6 weeks, 3, 6 and 
12 months as follow- up time points). The final REPORT- PFP 
checklist is provided in table 1, and freely available in online ( 
www. ipfrn. org).
DISCUSSION
The 31- item REPORT- PFP checklist will enhance clinical prac-
tice by improving research reporting and translation. It will also 
facilitate evidence synthesis, and guide clinicians on how they 
can contribute to research and data collection in their practice. 
We used thorough and engaging iterative methods to develop the 
checklist.26 This included guidance from an international expert 
panel, face- to- face and online consultation with large numbers 
of international patellofemoral pain researchers and clinicians, 
and multiple consensus voting rounds. Multiple opportunities 
for feedback were provided, and suggestions were incorporated 
before finalising the checklist and guidance.26 Our compre-
hensive approach resulted in most items being recommended 
through consensus voting. We encourage peer reviewers and 
editors to consider submission of the REPORT- PFP checklist 
with all quantitative patellofemoral pain studies, and emphasise 
Figure 3 Consensus voting results for outcome measures (A) and 
outcome measure description (B). Vertical bar indicates 70% threshold 
for strongly recommended (dark green crosses line) or recommended 
(light green crosses line).
Figure 4 Consensus voting results for reporting trial methodology 
(A) and reporting study results (B). Vertical bar indicates 70% threshold 
for strongly recommended (dark green crosses line) or recommended 
(light green crosses line). CERT, Complete Exercise Reporting Template; 
EQUATOR, Enhancing the QUAlity and Transparency OfHealth Research; 
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adherence to the 11 ‘strongly recommended’ items. The full 
checklist and associated recommendations of what to report 
(online supplemental appendix 4) will be freely available on the 
iPFRN website (https:// ipfrn. org/ report- pfp- checklist/) to guide 
researchers and clinicians.
Strongly recommended items
Two demographic and three baseline symptom items are strongly 
recommended (table 1), with adherence needed to improve 
evidence synthesis, and for clinicians to understand the applica-
bility of patellofemoral pain research findings to their patients. 
Participants’ sex is important, considering differences in muscle 
capacity and biomechanics between men and women with 
patellofemoral pain.35–39 Age is associated with greater muscle 
capacity impairments39 40 and development of patellofemoral 
osteoarthritis.41 42 Pain severity and symptom duration can 
impact prognosis in people with patellofemoral pain.14 Presence 
of unilateral or bilateral symptoms may reflect the magnitude 
of widespread pain and severity10 and/or reflect symmetrical 
mechanical features believed to relate to patellofemoral pain,43 
and could impact symptoms and prognosis.
Reporting pain severity and a condition- specific patient- 
reported outcome were strongly recommended, and will enable 
direct relationship of research findings to clinical presentations. 
We did not seek consensus on specific outcome measures, but 
further work with patients to address this will be carried out 
around the 2022 iPFRN retreat. In the interim, guidance notes 
provided in the REPORT- PFP checklist include suggestions of 
two condition- specific outcome measures—the Anterior Knee 
Pain Scale (AKPS)44 and/or Knee injury and Osteoarthritis 
Outcome Score Patellofemoral subscale (KOOS- PF).45 The 
AKPS44 is the most widely used condition- specific outcome for 
patellofemoral pain, and is valid, responsive, and has excel-
lent reliability in this population (intraclass correlation coeffi-
cient=0.81).46 KOOS- PF,45 published in 2018, was developed 
with input from 50 patients with patellofemoral pain and/or 
osteoarthritis and 14 healthcare professionals. Initial evaluation 
following the COSMIN checklist indicates adequate measure-
ment properties, including internal consistency, test–retest reli-
ability, validity and responsiveness.45 Regardless of outcome 
measure choice, describing them in adequate detail to allow 
replication is strongly recommended, and will assist replication 
studies and ensure clinicians can confidently apply evidence- 
based assessments in their clinical practice, reducing research 
waste.47
Reporting mean and SD for parametric data and median and 
IQR for non- parametric data, and 95% CIs for between- group 
differences is strongly recommended. These items were origi-
nally considered in the context of randomised controlled trial 
designs and between group differences. Following final consid-
eration, we also recommend that precision of estimate should 
be provided for all inferential statistics, as is recommended in 
reporting guides for observational studies such as STROBE.48 
Adherence to these strong recommendations reflect EQUATOR 
Network tools,21 and will address historic barriers to data 
synthesis and meta- analysis experienced by patellofemoral pain 
researchers seeking to guide clinical practice.
Recommended items
Reporting the 20 ‘recommended’ items from the checklist will 
help clinicians interpret if the study’s findings are applicable to 
the patient in front of them. Adherence will also reduce chal-
lenges frequently faced by researchers completing evidence 
synthesis due to heterogenous and often inadequately reported 
study details. Additionally, recommended items can also be used 
to guide planning of future research related to patellofemoral 
pain, including potential contribution to data collection by 
practicing clinicians. Suggestions for implementation, including 
specific instruments, are provided in online supplemental file 
4). Recommended demographic items including body mass, 
height and BMI have been inconsistently reported in past 
research,8 11 and physical activity49 and ethnicity are seldomly 
reported. Yet each may plausibly influence prognosis and treat-
ment outcomes,50–52 making them important considerations 
when interpreting research findings. Recommended baseline 
symptom items including knee crepitus, pain quality, pain loca-
tion and aggravating factors, will help researchers and clinicians 
understand the important characteristics of the population being 
investigated. For example, crepitus is associated with fear of 
damage,53 patellofemoral osteoarthritis on imaging54 and risk 
of symptomatic knee osteoarthritis development,55 all of which 
may influence prognosis and adherence to treatments such as 
exercise- therapy. Previous treatment, knee surgery history and 
other musculoskeletal complaints, and comorbidities may also 
influence prognosis,56 making them important to know.
Inclusion of GROC,57 psychological outcome measures (pain- 
related fear, pain catastrophising, self- efficacy), and health- 
related quality of life alongside self- reported pain and disability 
outcomes (eg, AKPS44) may provide important insight into treat-
ment outcomes and prognosis.9 13 58–61 Building on the strong 
Figure 5 Consensus voting results for items discussed at the International Patellofemoral ResearchNetwork 2019 retreat and voted on after the 
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recommendation to describe outcome measures in adequate 
detail to allow replication, providing, or linking to, videos and/
or images of any assessment or outcome measures is also recom-
mended where possible. This can facilitate important ‘how to’ 
guidance for clinicians to implement new assessments into prac-
tice,62 and improve the ease of completing replication studies for 
other research groups.47 Additionally, providing measurement 
properties including reliability and validity of those performing 
assessments will ensure the trustworthiness of data is clear to 
researchers and clinicians.63 Our consensus process could not 
provide consistent definitions for short- term, medium- term and 
long- term timeframes. However, the consistent use of 6, 13, 26 
and 52 weeks follow- up where possible for clinical trials was 
recommended through consensus voting.
Consensus voting supported EQUATOR Network21 recom-
mendations for relevant study designs (eg, CONSORT,64 
STROBE65), including the TIDiER checklist66 to report inter-
ventions with the addition of CERT67 68 for exercise interven-
tions. Adherence to these recommendations will help to address 
previous challenges with evidence synthesis and allow replica-
tion in future studies and clinical practice. For example, there 
is clear evidence that inadequate reporting of exercise- therapy 
programmes for patellofemoral pain has prevented recommen-
dations about what type of exercise- therapy, if any, might be 
best.17 Beyond the EQUATOR Network,21 the REPORT- PFP 
provides important additional recommendations related to 
intervention reporting. Studies evaluating resistance training 
interventions are recommended to include detailed informa-
tion based on the Toigo and Boutellier criteria,17 69 and provide 
videos and/or images of all interventions where possible to aid 
with replication in research and clinical practice.47 62
Clinical implications
Systematic reviews, consensus statements and clinical prac-
tice guidelines are typically highly cited, meaning they are 
often considered of high quality by researchers and funders,70 
and are sought by quality journals. Yet, the heterogeneous and 
inadequate reporting of study details in patellofemoral pain 
research has meant the credibility of these evidence syntheses is 
frequently hampered. Additionally, no guideline has been able 
to provide clear guidance on ‘how to’ apply assessment and 
treatment recommendations for patellofemoral pain in clinical 
practice.71 Ultimately, this reduces the trust clinicians place in 
using research to inform care they provide, stifling the transla-
tion of evidence and guidelines to practice, as is evident in the 
management of patellofemoral pain.72 73 Our work to develop 
and disseminate the REPORT- PFP checklist was urgently needed 
to improve the trustworthiness of evidence syntheses, and 
help clinicians optimise evidence- based practice. If translatable 
research findings such as effective intervention are more readily 
applied by clinicians, this will improve research impact through 
improved health outcomes.74 Our checklist and guidance notes 
(online supplemental appendix 4) will guide clinicians on how 
to embed data collection in their practice, and thus can facilitate 
development of a vital ‘real world’ evidence- base for one of the 
most commonly encountered musculoskeletal conditions.1
Limitations
Although we conducted extensive face- to- face and online consul-
tation with the international patellofemoral research community, 
20 of our 31 items were categorised as ‘recommended’, rather 
than ‘strongly recommended’. Our consensus voting to develop 
the REPORT- PFP checklist did not include patient voices and 
further work is planned to address this. This will focus on refining 
items included (ie, how/what to specifically report—eg, which 
patient reported outcomes). We expect this work will lead to 
many ‘recommended’ items becoming ‘strongly recommended’ 
Table 1 Checklist of strongly recommended and recommended items 
for quantitative patellofemoral pain studies
Section 1—items strongly recommended
(essential)
Reported on page # 
or N/A
Demographic items   
1 Sex or gender of the participants   
2 Age of the participants   
Baseline symptoms and previous treatment items   
3 Symptom duration   
4 Pain severity   
5 Unilateral/bilateral complaints   
Outcome measure items   
6 Condition- specific patient- reported outcome   
7 Pain severity   
Outcome measure description   
8 Describe assessment in adequate detail to allow 
replication
  
Reporting study results items   
9 Mean and SD for parametric data   
10 Median and IQR for non- parametric data   
11 Precision of estimate for all inferential statistics 




Reported on page # 
or N/A
Demographic items   
12 Anthropometrics (including body mass and height, 
or body mass index)
  
13 Physical activity   
14 Source/setting/location of participants   
15 Ethnicity of the participants   
Baseline symptoms and previous treatment items   
16 Previous treatment   
17 Pain location(s)   
18 Aggravating factors   
19 History of knee surgery   
20 Other complaints, musculoskeletal complaints and 
comorbidities
  
21 Crepitus   
22 Pain quality   
Outcome measure items   
23 Physical activity   
24 Global rating of change   
25 Health- related quality of life   
26 Psychological factors (including self- efficacy, pain- 
related fear and pain catastrophising)
  
Outcome measure description   
27 Provide measurement properties of assessments   
28 Provide videos and/or images of assessments   
Study methodology items, including reporting interventions   
29 Follow recommendations from EQUATOR 
Network21
  
30 Use existing checklists for interventions, including 
TIDiER66; CERT67 68 for exercise interventions; and 
Toigo and Boutellier17 69 for resistance training 
interventions
  
31 Provide videos and/or images of treatments   
CERT, Complete Exercise Reporting Template; EQUATOR, Enhancing the QUAlity and 
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in the future. Health professional training of our experts in 
the final round of consensus voting (2019) was predominantly 
physiotherapy/physical therapy (52%), with limited representa-
tion of researchers with a medical training (8%). The consensus 
participants are representative of the main research and clinical 
community treating patellofemoral pain. However, seeking addi-
tional feedback and critique of this checklist from general prac-
titioners, rheumatologists, sports physicians and surgeons, who 
also commonly manage and research people with patellofemoral 
pain, may help to optimise acceptance and adoption.
We have not provided specific guidance for reporting biome-
chanical and imaging research in people with patellofemoral 
pain, with further work planned to extend the checklist to 
cover these specific fields of research. A concurrent iPFRN 
consensus related to pain and psychological features in the field 
of patellofemoral pain was developed during the 2019 iPFRN 
retreat,75 providing guidance to researchers working in these 
fields. Evaluating uptake and effectiveness of the REPORT- PFP 
checklist, and iterative refinement will be priorities for this group. 
User feedback will be facilitated via an embedded survey on the 
iPFRN website (https:// ipfrn. org/ report- pfp- checklist/), allowing 
researchers and clinicians to evaluate usability and applicability, 
and providing an opportunity for suggestions on refinement. We 
expect the REPORT- PFP checklist to evolve based on this feed-
back, emerging evidence, understanding related to patellofem-
oral pain, and patient input. Any updates will be provided via 
the iPFRN website.
CONCLUSION
Strong recommendations about what essential items should be 
reported, along with a larger list of recommended items that 
should be considered in future patellofemoral pain research are 
provided. Strong stakeholder engagement during development 
of the REPORT- PFP checklist means consistent application by 
the international patellofemoral pain research community is 
likely. Adherence to the checklist, which provides standards for 
REPORT- PFP should improve clinical translation, clarity and 
trustworthiness of evidence syntheses, and guide sports medicine 
clinicians on how to collect data in their own practice.
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